Eoflow Co., Ltd. (294090)
Market Closed
10 Aug, 06:30
KRX SM KRX SM Primary ₩
1,490. 00
0
0%
₩
52.27B Market Cap
- P/E Ratio
- Div Yield
857,110 Volume
- Eps
₩ 1,490
Previous Close Want to track 294090 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
294090 closed yesterday higher at ₩1,490, an increase of 0% from Friday's close, completing a monthly increase of 0% or ₩0. Over the past 12 months, 294090 stock gained 0%.
294090 is not paying dividends to its shareholders.
The last earnings report, released on Mar 27, 2025, missed the consensus estimates by -894.6804%. On average, the company has fell short of earnings expectations by -298.2268%, based on the last three reports.
Eoflow Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jan 17, 2022.
The company's stock is traded on one exchange.
Eoflow Co., Ltd. (294090) FAQ
What is the stock price today?
The current price is ₩1,490.00.
On which exchange is it traded?
Eoflow Co., Ltd. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 294090.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 52.27B.
Has Eoflow Co., Ltd. ever had a stock split?
Eoflow Co., Ltd. had 2 splits and the recent split was on Jan 17, 2022.
Eoflow Co., Ltd. Profile
| Health Care Technology Industry | Healthcare Sector | - CEO | KRX SM Exchange | KR7294090006 ISIN |
| South Korea Country | 62 Employees | - Last Dividend | 17 Jan 2022 Last Split | - IPO Date |
Overview
EOFLOW Co.,Ltd., established in 2011, specializes in developing and delivering advanced drug delivery solutions. The company is headquartered in Seongnam, South Korea, and aims to enhance the quality of life for patients requiring regular drug administration by offering innovative technologies. By focusing on user-friendly wearable products, EOFLOW stands at the forefront of redefining therapeutic treatments in terms of convenience and effectiveness.
Products and Services
- EOPatch - A state-of-the-art wearable insulin pump system designed to provide diabetics with a more flexible and discreet method of insulin delivery. Unlike traditional insulin delivery methods, the EOPatch allows for continuous insulin infusion, making it an effective solution for managing blood glucose levels. Its compact and wearable design facilitates ease of use and improves the user's quality of life by offering a seamless way to receive insulin without the need for frequent injections or manual pump adjustments.
Contact Information
Address: Healthcare Innovation Park Number H2102
Phone: 82-31-738-0204
Website: https://www.eoflow.com
